| Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy KM Mahadeo, SJ Khazal, H Abdel-Azim, JC Fitzgerald, A Taraseviciute, ... Nature Reviews Clinical Oncology 16 (1), 45-63, 2019 | 195 | 2019 |
| The indoleamine 2, 3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma M Li, AR Bolduc, MN Hoda, DN Gamble, SB Dolisca, AK Bolduc, K Hoang, ... Journal for immunotherapy of cancer 2, 1-13, 2014 | 151 | 2014 |
| Diagnosis, grading and management of toxicities from immunotherapies in children, adolescents and young adults with cancer D Ragoonanan, SJ Khazal, H Abdel-Azim, D McCall, B Cuglievan, ... Nature Reviews Clinical Oncology 18 (7), 435-453, 2021 | 40 | 2021 |
| Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma ER Molina, LK Chim, MC Salazar, SM Mehta, BA Menegaz, ... Acta biomaterialia 100, 38-51, 2019 | 32 | 2019 |
| Venetoclax for children and adolescents with acute lymphoblastic leukemia and lymphoblastic lymphoma A Gibson, A Trabal, D McCall, S Khazal, L Toepfer, DH Bell, M Roth, ... Cancers 14 (1), 150, 2021 | 31 | 2021 |
| Self‐diffusion and nuclear relaxation in polyisobutylene DW McCall, DC Douglass, EW Anderson Journal of Polymer Science Part A: General Papers 1 (5), 1709-1720, 1963 | 30 | 1963 |
| Aerial high-throughput phenotyping of peanut leaf area index and lateral growth S Sarkar, AB Cazenave, J Oakes, D McCall, W Thomason, L Abbott, ... Scientific Reports 11 (1), 21661, 2021 | 27 | 2021 |
| High‐throughput measurement of peanut canopy height using digital surface models S Sarkar, AB Cazenave, J Oakes, D McCall, W Thomason, L Abbot, ... The Plant Phenome Journal 3 (1), e20003, 2020 | 27 | 2020 |
| Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy KM Mahadeo, SJ Khazal, H Abdel-Azim, JC Fitzgerald, A Taraseviciute, ... Nat Rev Clin Oncol 16 (1), 45-63, 2019 | 25 | 2019 |
| IGF-1R/mTOR targeted therapy for Ewing sarcoma: a meta-analysis of five IGF-1R-related trials matched to proteomic and radiologic predictive biomarkers HM Amin, AC Morani, NC Daw, SE Lamhamedi-Cherradi, V Subbiah, ... Cancers 12 (7), 1768, 2020 | 22 | 2020 |
| Pediatric ependymoma: current treatment and newer therapeutic insights S Khatua, R Mangum, KC Bertrand, W Zaky, D McCall, SC Mack Future Oncology 14 (30), 3175-3186, 2018 | 21 | 2018 |
| The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma SE Lamhamedi-Cherradi, M Maitituoheti, BA Menegaz, S Krishnan, ... Nature communications 13 (1), 3057, 2022 | 16 | 2022 |
| Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma SE Lamhamedi-Cherradi, S Mohiuddin, DK Mishra, S Krishnan, ... Cancer gene therapy 28 (12), 1325-1338, 2021 | 16 | 2021 |
| Outcomes of isolated neutropenia referred to pediatric hematology-oncology clinic V Nagalapuram, D McCall, P Palabindela, TH Howard, C Bemrich-Stolz, ... Pediatrics 146 (4), 2020 | 11 | 2020 |
| Long-term outcomes among adolescent and young adult survivors of acute leukemia: a surveillance, epidemiology, and end results analysis AM Berkman, CR Andersen, B Cuglievan, DC McCall, PJ Lupo, ... Cancer Epidemiology, Biomarkers & Prevention 31 (6), 1176-1184, 2022 | 10 | 2022 |
| Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia D McCall, M Roth, KM Mahadeo, L Toepfer, C Nunez, NJ Short, N Daver, ... Blood Advances 5 (23), 5215-5219, 2021 | 10 | 2021 |
| Venetoclax for acute myeloid leukemia in pediatric patients: a Texas Medical Center Experience A Trabal, A Gibson, J He, D McCall, M Roth, C Nuñez, M Garcia, ... Cancers 15 (7), 1983, 2023 | 8 | 2023 |
| Critical care of the pediatric immunocompromised Hematology/Oncology patient: An evidence-based guide CN Duncan, JAM Talano, JA McArthur Springer, 2019 | 7 | 2019 |
| Early results of the phase I/II study investigating the all-oral combination of the menin inhibitor revumenib (SNDX-5613) with decitabine/cedazuridine (ASTX727) and venetoclax … GC Issa, B Cuglievan, CD DiNardo, NJ Short, D McCall, A Gibson, ... Blood 142, 58, 2023 | 6 | 2023 |
| Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients ER Molina, LK Chim, SE Lamhamedi-Cherradi, S Mohiuddin, D McCall, ... Oncotarget 13, 521, 2022 | 6 | 2022 |
